Literature DB >> 1858027

Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin.

P A van Leeuwen1, R W Hong, J D Rounds, M L Rodrick, D Wilmore.   

Abstract

Despite significant improvements in the surgical care of patients, hepatic failure after extensive liver resection continues to be associated with a high morbidity and death. We postulated that hepatic failure after liver resection was related to gut-derived endotoxemia. Rats were randomized to receive oral gavage twice daily with one of the following preparations: (1) 0.9% saline; (2) neomycin sulfate and cefazolin; (3) cholestyramine; (4) lactulose. After 7 days of gavage, animals underwent either a two-thirds partial hepatectomy or sham operation. At time 0 (preresection), 10, 20, and 30 hours after resection, aortic blood was obtained for determination of ammonia, glutamine, and endotoxin levels. In selected animals, portal vein or inferior caval blood was obtained simultaneously with the aortic sample to evaluate the glutamine and ammonia exchange across the intestine and hind limb. Germ-free rats also underwent a partial hepatectomy or sham operation, and blood was obtained for glutamine and ammonia exchange at 0 and 20 hours after resection. Hepatectomy in the saline-pretreated rats resulted in a sixfold increase in plasma glutamine, increased uptake of glutamine and release of ammonia by the gut, increased release of glutamine by the hind-limb, and a high mortality rate. Pretreatment with agents that altered gut contents reduced the endotoxemia, maintained normal glutamine and ammonia levels, and reduced the mortality rate. Germ-free rats had a similar response to that seen in treated animals. Altering the gut contents in this model reduced the level of endotoxemia, blunted the catabolic response, and enhanced survival.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1858027     DOI: 10.1016/0261-5614(91)90171-8

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  [Prevention of spontaneous bacterial peritonitis by lactulose?].

Authors:  H Huchzermeyer; T Grünewald; C Schumann
Journal:  Med Klin (Munich)       Date:  1999-11-15

2.  Culture-proven small intestinal bacterial overgrowth as a cause of irritable bowel syndrome: response to lactulose but not broadspectrum antibiotics.

Authors:  Jelica Kurtovic; Isidor Segal; Stephen M Riordan
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

3.  Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models.

Authors:  Guo-Qing Zang; Xia-Qiu Zhou; Hong Yu; Qing Xie; Guo-Ming Zhao; Bin Wang; Qing Guo; Yue-Qin Xiang; Dan Liao
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  Mechanisms of splenic hypertrophy following hepatic resection.

Authors:  Gheorghe Petrovai; Stéphanie Truant; Carole Langlois; Ahmed F Bouras; Stéphanie Lemaire; David Buob; Emmanuelle Leteurtre; Emmanuel Boleslawski; François-René Pruvot
Journal:  HPB (Oxford)       Date:  2013-02-26       Impact factor: 3.647

5.  Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; R I Wesdorp; M L Rodrick; D W Wilmore
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

6.  G-CSF pretreatment aggravates LPS-associated microcirculatory dysfunction and acute liver injury after partial hepatectomy in rats.

Authors:  Anding Liu; Haoshu Fang; Weiwei Wei; Chunyi Kan; Chichi Xie; Uta Dahmen; Olaf Dirsch
Journal:  Histochem Cell Biol       Date:  2014-07-25       Impact factor: 4.304

7.  Changes of gut flora and endotoxin in rats with D-galactosamine-induced acute liver failure.

Authors:  Lan-Juan Li; Zhong-Wen Wu; Dang-Sheng Xiao; Ji-Fang Sheng
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

8.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 9.  Clinical significance of translocation.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; C C Ferwerda; M A Cuesta; S Meyer; R I Wesdorp
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats.

Authors:  Chang-Jun Jia; Chao-Liu Dai; Xu Zhang; Kai Cui; Feng Xu; Yong-Qing Xu
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.